NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-130-2002-0-IN-07 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE IN National Stage 1390/DELNP/2005 Abandoned
NIAID E-092-2002-0-JP-06 (HPIV2) Form cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens JP National Stage 2004-538335 Abandoned
NIAID E-092-2002-0-AU-07 Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens AU National Stage 2003270824 Abandoned
NCI E-116-2001-0-US-14 Formulation of Boronic Acid Compounds US CON 10/664,732 6958319 Expired PDF
NIAID E-130-2002-0-PCT-02 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE PCT PCT PCT/US2003/029833 Expired
NIAID E-092-2002-0-PCT-03 (HPIV2) Form cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens PCT PCT PCT/US03/29685 Expired
NIAID E-130-2002-0-EP-12 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE EP DIV 09175598.3 Abandoned
NIAID E-130-2002-0-BR-05 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE BR National Stage PI0314629-4 Abandoned
NIAID E-130-2002-0-EP-04 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE EP National Stage 03759395.1 Abandoned
NCI E-315-2003-0-US-01 SH2 Domain Binding Inhibitors US 60/504,241 Abandoned
NIAID E-130-2002-0-IN-10 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE IN DIV 0196/DELNP/2008 Abandoned
NIAID E-130-2002-0-IL-08 P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE IL National Stage 167515 Abandoned
NIAID E-092-2002-0-CA-04 Recovery of Recombinant HPIV2 from cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and other Human Pathogens CA National Stage 2499404 Abandoned
NCI E-079-2004-0-GB-02 BIOLOGICAL MATERIALS AND USES THEREOF GB ORD 0321746.0 Abandoned
NIA E-189-2003-0-US-01 Thalidomide Analogs US 60/504,724 Abandoned
NIAID E-284-2004-0-US-01 TNR-2 Facilitated Programmed Necrosis US 60/503,926 Abandoned
NCI E-050-2000-0-US-15 Geldanamycin Derivative and Method of Treating Cancer Using Same US National Stage 10/432,581 6890917 Expired PDF
NIDA E-251-2002-1-CA-04 Structurally Rigid Dopamine D3 Receptor Selective Ligands And Process For Making Them CA National Stage 2498936 Abandoned
NIDA E-251-2002-1-AU-03 Structurally Rigid Dopamine D3 Receptor Selective Ligands and Process for Making Them AU National Stage 2003267201 Abandoned
NIDA E-251-2002-1-PCT-01 STRUCTURALLY RIGID DOPAMINE D3 RECEPTOR SELECTIVE LIGANDS AND PROCESS FOR MAKING THEM PCT PCT COMB PCT/US03/28895 Expired
NINDS E-012-2000-0-US-03 Postsynaptic Response By Increasing Intracellular Calcium US National Stage 10/471,691 Abandoned
NIAID E-334-2003-0-US-01 Reagents And Approaches Relevant To The Diagnosis, Vaccinationa And Treatment Of SARS And Analysis Fo The Immune Response. US 60/503,508 Abandoned
NIAID E-335-2003-0-US-01 Mechanisms For Improving The Breadth Of The Immune Response To Diverse Strains And Clades For HIV US 60/503,509 Abandoned
NCI E-029-2005-0-US-01 Enhanced Immunogenicity Of A Replicating Ad-recombinant Priming/oligomeric Gp140V2 Boosting Vaccine Regimen US 60/504,501 Abandoned
NIDCR E-308-2003-3-PCT-01 METHODS OF DIAGNOSING AND TREATING HYPERPROLIFERATIVE DISORDERS PCT PCT COMB PCT/US2003/028742 Expired
NIAID E-286-2002-2-PCT-01 Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis PCT PCT COMB PCT/US03/28889 Expired
NIMH E-110-1993-0-US-18 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE PHYSICO-CHEMICALLY ALTERED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CON 10/659,698 7332307 Abandoned PDF
NCI E-054-2003-0-US-01 Determining Kinase Specificity US ORD 10/660,370 Abandoned
NIMH E-110-1993-0-US-19 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CON 10/659,711 Abandoned
NCI E-320-2005-0-US-02 Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo US ORD 10/660,369 Abandoned
NIAID E-033-1996-1-AU-09 MODIFIED MYELIN PROTEIN MOLECULES AU DIV 2003246018 Abandoned
NHLBI E-223-2002-0-AU-06 FACTORS THAT BIND INTESTINAL TOXINS AU National Stage 2003267079 Abandoned
NIMH E-002-2004-1-US-01 Trans-Splicing Mediated Photodynamic Therapy US CIP 10/658,617 7399753 Expired PDF
NHLBI E-223-2002-0-PCT-02 FACTORS THAT BIND INTESTINAL TOXINS PCT PCT PCT/US03/28282 Expired
NCI E-058-1998-0-US-05 PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE US CON 10/659,036 Abandoned
NHLBI E-223-2002-0-EP-04 FACTORS THAT BIND INTESTINAL TOXINS EP National Stage 03749554.6 Abandoned
NHLBI E-223-2002-0-CA-07 FACTORS THAT BIND INTESTINAL TOXINS CA National Stage 2498225 Abandoned
NEI E-220-2001-0-SG-22 Nutritional Supplement to Treat Macular Degeneration SG DIV 200403488-0 Expired
NCI E-215-2003-0-US-01 Protocol And Software For Multiplex Real Time PCR Quantification Based On The Different Melting Temperatures Of Amplicons US ORD 10/658,602 Abandoned
NCI E-246-2003-0-US-01 Non Peptide Agonists and Antogonists of Adrenomedullin (AM) And Gastrin Releasing Peptide US 60/500,650 Abandoned
NCI E-276-2005-0-US-01 Novel Small Molecule Inhibitors Of Botulinum Neurotoxin Metalloprotease Activity US 60/501,243 Abandoned
NCI E-275-2002-1-EP-03 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy EP National Stage 03794636.5 Expired
NCI E-275-2002-1-CA-04 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy CA National Stage 2497552 Expired
NCI E-035-2002-0-CA-05 Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same CA National Stage 2495442 Abandoned
NCI E-082-2004-2-AU-06 Methods of Preventing or Treating T Cell Malignancies by Adminstering CD2 Antagonists AU National Stage 2003273299 Abandoned
NCI E-275-2002-1-AU-05 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy AU National Stage 2003265948 Expired
NCI E-035-2002-0-AU-04 Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same AU National Stage 2003270347 Abandoned
NCI E-239-2002-0-PCT-02 MINIMALLY IMMUNOGENIC VARIANTS OF HUMANIZED COL-1 ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN PCT PCT PCT/US2003/027976 Expired
NCI E-082-2004-2-PCT-01 Methods of Preventing or Treating T Cell Malignancies by Adminstering CD2 Antagonists PCT PCT COMB PCT/US2003/028088 Expired
NCI E-035-2002-0-PCT-02 Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same PCT PCT PCT/US03/27878 Expired